Ardelyx, Inc. (ARDX)
NASDAQ·Healthcare·Biotechnology
$5.97
-0.33%
Mkt Cap $1.46B
EPS — Estimate vs Actual
Revenue — Estimate vs Actual
Quarterly History
| Q1 2026 Feb 19, 2026 | $118.05M | $125.22M | +6.07% | $0.02 | $0.02 | +0.00% | — | — |
| Q4 2025 Oct 30, 2025 | $119.06M | $110.33M | -7.33% | -$0.06 | -$0.00 | +93.32% | — | — |
| Q3 2025 Aug 4, 2025 | $94.63M | $97.66M | +3.21% | -$0.13 | -$0.08 | +38.46% | — | — |
| Q2 2025 May 1, 2025 | $79.44M | $74.11M | -6.71% | -$0.10 | -$0.17 | -70.00% | — | — |
| Q1 2025 Feb 20, 2025 | $74.54M | $116.13M | +55.79% | $0.02 | $0.02 | +0.00% | — | — |
| Q4 2024 Oct 31, 2024 | $108.57M | $98.24M | -9.51% | -$0.05 | -$0.00 | +93.14% | — | — |
| Q3 2024 Aug 1, 2024 | $55.02M | $73.22M | +33.08% | -$0.10 | -$0.07 | +30.00% | — | — |
| Q2 2024 May 2, 2024 | $36.40M | $46.02M | +26.44% | -$0.13 | -$0.11 | +15.38% | — | — |
| Q1 2024 Feb 22, 2024 | $34.23M | $34.36M | +0.39% | -$0.09 | -$0.12 | -33.33% | — | — |
| Q4 2023 Oct 31, 2023 | $31.39M | $56.39M | +79.65% | -$0.11 | $0.03 | +127.27% | — | — |
| Q3 2023 Aug 2, 2023 | $15.27M | $22.33M | +46.25% | -$0.12 | -$0.08 | +33.33% | — | — |
| Q2 2023 May 3, 2023 | $10.60M | $11.37M | +7.25% | -$0.11 | -$0.13 | -18.18% | — | — |
| Q1 2023 Mar 2, 2023 | $23.18M | $44.18M | +90.63% | $0.00 | $0.06 | +6085.57% | — | — |
| Q4 2022 Nov 3, 2022 | $3.92M | $4.99M | +27.14% | -$0.17 | -$0.14 | +17.65% | — | — |
| Q3 2022 Aug 4, 2022 | $2.22M | $2.53M | +13.73% | -$0.19 | -$0.19 | +0.00% | — | — |
| Q2 2022 May 5, 2022 | $875.00K | $468.00K | -46.51% | -$0.20 | -$0.21 | -5.00% | — | — |
| Q1 2022 Feb 28, 2022 | $875.50K | $1.03M | +17.53% | -$0.25 | -$0.31 | -24.00% | — | — |
| Q4 2021 Nov 12, 2021 | $700.00K | $1.17M | +67.57% | -$0.34 | -$0.42 | -23.53% | — | — |
| Q3 2021 Aug 13, 2021 | $1.31M | $1.31M | +0.00% | -$0.36 | -$0.45 | -25.00% | — | — |
| Q2 2021 May 6, 2021 | $6.38M | $6.58M | +3.13% | -$0.32 | -$0.34 | -6.25% | — | — |